Penguin Ai vs Waystar

Utilization management at a health plan sends it to Penguin Ai, whose Intelligent UM handles prior authorization, concurrent and retro review and appeals for payers. A provider finance team looking at Waystar gets financial clearance, clinical integrity, revenue capture and analytics, and the vendor cites 1M+ providers.

Penguin also sells to providers, with HCC coding and a loop of pre-submission review and denial recovery over Epic FHIR and Cerner connectors, so denial recovery is where the two meet. A hospital revenue cycle team working a denial queue finds claim monitoring, denial recovery and remittance listed as one Waystar suite, and pre-submission review and denial recovery as one closed loop in Penguin's Intelligent RCM. The vendors' own pages give no basis to pick between them on that work. Waystar listed on Nasdaq in June 2024 and closed its purchase of Iodine Software for $1.25B (currency not stated) around October 1, 2025. Penguin Ai was founded in 2024 and announced US$29.7M in funding in September 2025, including a US$25M Series A led by Greycroft.